Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
Psychologie & Neuropsychiatrie Du Vieillissement|January 12, 2010
[Brain functional imaging in Alzheimer's disease]Laura Ravasi, Franck SemahCNS & Neurological Disorders Drug Targets|May 19, 2016
Translational Challenge Models in Support of Efficacy Studies: Effect of Cerebral Hypoxia on Cognitive Performances in RodentsJulie Deguil, Laura Ravasi, Laura Lanteaume, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 6, 2007
Operational lumped constant for FDG in normal adult male ratsJoji Tokugawa, Laura Ravasi, Toshiyuki Nakayama, et al.Brain : a Journal of Neurology|October 16, 2012
My belief or yours? Differential theory of mind deficits in frontotemporal dementia and Alzheimer's diseaseRaphaël Le Bouc, Pierre Lenfant, Xavier Delbeuck, et al.Nuclear Medicine and Biology|August 12, 2011
Imaging of the muscarinic acetylcholine neuroreceptor in rats with the M2 selective agonist [18F]FP-TZTPLaura Ravasi, Joji Tokugawa, Toshiyuki Nakayama, et al.Nuclear Medicine Communications|February 18, 2011
Use of [18F]fluorodeoxyglucose and the ATLAS small animal PET scanner to examine cerebral functional activation by whisker stimulation in unanesthetized ratsLaura Ravasi, Kazuaki Shimoji, Marisa L Soto-Montenegro, et al.CNS & Neurological Disorders Drug Targets|May 19, 2016
Early Development of Symptomatic Drugs in AD: A Systematic Review of the Use of BiomarkersJulie Deguil, Laura Ravasi, Yves Lamberty, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 12, 2008
Calculation of electron dose to target cells in a complex environment by Monte Carlo code "CELLDOSE"Elif Hindié, Christophe Champion, Paolo Zanotti-Fregonara, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Evaluation of (76)Br-FBAU as a PET reporter probe for HSV1-tk gene expression imaging using mouse models of human gliomaSteve Y Cho, Laura Ravasi, Lawrence P Szajek, et al.Melanoma Research|July 16, 2013
Patient-derived tumor xenograft model to guide the use of BRAF inhibitors in metastatic melanomaPierre Guerreschi, Camille Scalbert, Ahmad Qassemyar, et al.Pageof 3